Cabometyx (cabozantinib tablets) — Cigna
Neuroendocrine tumors (pancreatic or extra-pancreatic)
Initial criteria
- Patient age ≥ 12 years
- Patient has locally advanced, unresectable, or metastatic disease
- Patient has well-differentiated neuroendocrine tumors
- Tumor type is pancreatic neuroendocrine tumor OR extra-pancreatic neuroendocrine tumor
- Medication will be used as subsequent therapy
Approval duration
1 year